Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial

Paritosh Prasai1, Dhan Bahadur Shrestha2, Eltaib Saad1

  • 1Department of Internal Medicine, Ascension Health St. Francis Hospital, Evanston, IL 60202, USA.

Insights

Pharmacological cardioversion and electrical cardioversion show similar success rates for new-onset atrial fibrillation. This meta-analysis found no significant differences in outcomes for stable patients, with electrical cardioversion having lower hypotension rates.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Research

Background:

  • Lack of consensus exists regarding the preferred cardioversion method for hemodynamically stable new-onset atrial fibrillation (NOAF) patients in the emergency department (ED).
  • Pharmacological cardioversion (PC) and electrical cardioversion (EC) are both utilized, necessitating a comparative analysis.

Purpose of the Study:

  • To compare the efficacy and safety of pharmacological cardioversion (PC) versus electrical cardioversion (EC) for hemodynamically stable new-onset atrial fibrillation (NOAF) patients.
  • To evaluate successful restoration of sinus rhythm and secondary outcomes including revisits, readmissions, length of stay, and adverse events.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies published up to March 7, 2022.
  • Searched PubMed, PubMed Central, Embase, Scopus, and Cochrane databases.
  • Primary outcome: successful sinus rhythm restoration; Secondary outcomes: ED revisits, hospital readmissions, length of stay, adverse events.

Main Results:

  • No significant difference in successful sinus rhythm restoration rates between PC and EC (88.66% vs. 85.25%).
  • No statistical differences observed in ED revisits, hospital readmissions, or length of stay.
  • Electrical cardioversion (EC) was associated with a lower incidence of hypotension compared to pharmacological cardioversion (PC).

Conclusions:

  • Pharmacological cardioversion (PC) and electrical cardioversion (EC) demonstrate comparable success rates for restoring sinus rhythm in hemodynamically stable new-onset atrial fibrillation (NOAF) patients.
  • Neither method showed superiority regarding revisits, readmissions, or length of hospital stay.
  • Electrical cardioversion (EC) may be preferred due to a lower risk of hypotension.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
69
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
25
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
60
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
104
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
47
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
44